Approval · Notice of Compliance 5341 · 1994
ASTRIX 500: Notice of Compliance 5341
Issued January 14, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5341
- Date
- January 14, 1994
- Company
- Faulding Pharms, Division Of Fh Faulding Co Ltd.Salisbury South, South Australia, Australia
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Analgesic, anti-inflammatory, antipyretic, platelet aggregation inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASTRIX 500 | 02065789 | — |
Medicinal ingredients
- ACETYLSALICYLIC ACID 500 MG per CAP